Published 14 days ago • loading... • Updated 14 days ago

Human Organoids Market Set to Reach $2.33 Billion by 2029

The global Human Organoids Market is projected to reach $2.33 billion by 2029, growing at a CAGR of 14.4% from its 2024 value of $1.19 billion.
Increasing need to reduce animal testing, combined with growing regulatory and public pressure for ethical research practices, is positioning organoids as a preferred alternative.
The Matrigel matrix culture segment emerged as the dominant method in 2023, supporting growth across multiple organ systems including the liver.
Pharma and Biotech Companies are leveraging biological models for Drug Toxicity testing and Personalized Medicine, unlocking new innovation pathways for industry players.
In Canada, advanced healthcare infrastructure and strong investment in biomedical innovation are driving adoption, with key industry players like Thermo Fisher Scientific Inc. and Merck KGaA shaping competition.

Insights by Ground AI